Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)

South Korea · Delayed Price · Currency is KRW

6,100.00

-10.00 (-0.16%)

At close: Jul 31, 2026

KOSDAQ:036480 Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	25,870	25,989	23,804	25,562	25,500	23,997
Revenue Growth	10.50%	9.18%	-6.88%	0.24%	6.26%	-3.24%
Gross Profit	6,252	6,320	3,932	4,705	4,645	5,593
Operating Income	532.91	714.27	-1,552	-689.01	-327.52	337.11
Net Income	653.72	598.19	-1,769	-679.68	1,703	865.92
Earnings Per Share	172.03	157.42	-465.62	-178.86	448.21	227.87
EPS Growth	-	-	-	-	96.69%	-42.98%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	9,432	9,388	9,053	11,727	12,859	9,935
Total Debt	19,812	19,978	20,428	24,011	22,029	22,352
Net Cash (Debt)	-10,380	-10,589	-11,374	-12,284	-9,170	-12,418
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-2731.58	-2786.71	-2993.19	-3232.58	-2413.27	-3267.79

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	1,784	1,410	2,103	-1,234	1,155	2,203
Capital Expenditures	-374.84	-355.64	-795.32	-1,256	-2,315	-2,968
Free Cash Flow	1,409	1,054	1,308	-2,490	-1,160	-764.71
Free Cash Flow Growth	-14.52%	-19.37%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	24.17%	24.32%	16.52%	18.40%	18.22%	23.31%
Operating Margin	2.06%	2.75%	-6.52%	-2.70%	-1.28%	1.41%
Pretax Margin	1.54%	1.29%	-6.60%	-4.23%	8.86%	3.51%
Profit Margin	2.53%	2.30%	-7.43%	-2.66%	6.68%	3.61%
FCF Margin	5.45%	4.06%	5.49%	-9.74%	-4.55%	-3.19%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	35.46	46.37	-	-	22.98	62.97
P/FCF Ratio	16.45	26.31	26.41	-	-	-
PS Ratio	0.90	1.07	1.45	1.63	1.54	2.27